Investor mix
2 investors on record; lead investors include Advent Life Sciences, Shire.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Small molecule drugs for CNS diseases
2 investors on record; lead investors include Advent Life Sciences, Shire.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |